Statins under-treatment and mortality in patients with atrial fibrillation. Insights from the nationwide START registry

Statins are mainstream drugs for cardiovascular (CV) prevention, but under-prescription is an important clinical challenge. Data on the use of single statins as the rate of under-prescription in atrial fibrillation (AF) are lacking. To evaluate the association of statin underuse with mortality risk in a large AF cohort.

Source: Nutrition, Metabolism, and Cardiovascular Diseases : NMCD - July 27, 2023 Category: Nutrition Authors: Danilo Menichelli, Emilia Antonucci, Pasquale Pignatelli, Francesco Violi, Gualtiero Palareti, Daniele Pastori, the START2 Register Investigators Source Type: research